Literature DB >> 10646691

Inhibition of rat brain lipid synthesis in vitro by 4-hydroxybutyric acid.

A R Silva1, C Ruschel, C Helegda, A M Brusque, C M Wannmacher, M Wajner, C S Dustra-Filho.   

Abstract

4-Hydroxybutyric acid (4HB) is accumulated in succinic semialdehyde dehydrogenase deficiency, an inherited metabolic disease severely affecting the CNS during postnatal development. Thus, the present study was designed to evaluate the in vitro influence of 4HB on lipid synthesis and CO2 production from [U-14C] acetate in cerebral cortex of 30-day-old Wistar rats. In the presence of 4HB, there was an inhibition of lipid synthesis in cerebral cortex prisms and homogenates. However, no inhibition of lipid synthesis occurred in the homogenates free of nuclei and mitochondria. In addition, CO2 production was inhibited by 4HB in cerebral cortex prisms, and homogenates and in the mitochondrial fraction. These results might possibly be explained by an impairment of mitochondrial metabolism by 4HB which may secondarily inhibit lipid synthesis. The results reported here may help to better understand the neuropathophysiology of 4-hydroxybutyric aciduria.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10646691     DOI: 10.1023/a:1020658624567

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  34 in total

1.  Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential?

Authors:  R Bernasconi; P Mathivet; S Bischoff; C Marescaux
Journal:  Trends Pharmacol Sci       Date:  1999-04       Impact factor: 14.819

2.  Regional brain levels of gamma-hydroxybutyrate in Huntington's disease.

Authors:  N Ando; B I Gold; E D Bird; R H Roth
Journal:  J Neurochem       Date:  1979-02       Impact factor: 5.372

3.  Fatty acid transport and utilization for the developing brain.

Authors:  J Edmond; T A Higa; R A Korsak; E A Bergner; W N Lee
Journal:  J Neurochem       Date:  1998-03       Impact factor: 5.372

Review 4.  Gamma hydroxybutyrate.

Authors:  O C Snead
Journal:  Life Sci       Date:  1977-06-15       Impact factor: 5.037

5.  Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids.

Authors:  W H Oldendorf
Journal:  Am J Physiol       Date:  1973-06

6.  4-Hydroxybutyric aciduria: a new inborn error of metabolism. I. Clinical review.

Authors:  D Rating; F Hanefeld; H Siemes; J Kneer; C Jakobs; M Hermier; P Divry
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

7.  The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients.

Authors:  K M Gibson; E Christensen; C Jakobs; B Fowler; M A Clarke; G Hammersen; K Raab; J Kobori; A Moosa; B Vollmer; E Rossier; A K Iafolla; D Matern; O F Brouwer; J Finkelstein; F Aksu; H P Weber; J A Bakkeren; F J Gabreels; D Bluestone; T F Barron; P Beauvais; D Rabier; C Santos; W Lehnert
Journal:  Pediatrics       Date:  1997-04       Impact factor: 7.124

Review 8.  The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies.

Authors:  F Poldrugo; G Addolorato
Journal:  Alcohol Alcohol       Date:  1999 Jan-Feb       Impact factor: 2.826

9.  Glial-neuronal interactions as studied by cerebral metabolism of [2-13C]acetate and [1-13C]glucose: an ex vivo 13C NMR spectroscopic study.

Authors:  B Hassel; U Sonnewald; F Fonnum
Journal:  J Neurochem       Date:  1995-06       Impact factor: 5.372

10.  Diminished concentrations of ganglioside N-acetylneuraminic acid (G-NeuAc) in cerebellum of young rats receiving chronic administration of methylmalonic acid.

Authors:  M Wajner; E C Brites; J C Dutra; M S Buchalter; A H Pons; R F Pires; L E Wannmacher; A Rosa Júnior; V M Trindade; C M Wannmacher
Journal:  J Neurol Sci       Date:  1988-06       Impact factor: 3.181

View more
  7 in total

1.  Inhibition of energy production in vitro by glutaric acid in cerebral cortex of young rats.

Authors:  C G Silva; A R Silva; C Ruschel; C Helegda; A T Wyse; C M Wannmacher; C S Dutra-Filho; M Wajner
Journal:  Metab Brain Dis       Date:  2000-06       Impact factor: 3.584

2.  L-pyroglutamic acid inhibits energy production and lipid synthesis in cerebral cortex of young rats in vitro.

Authors:  A R Silva; C G Silva; C Ruschel; C Helegda; A T Wyse; C M Wannmacher; M Wajner; C S Dutra-Filho
Journal:  Neurochem Res       Date:  2001-12       Impact factor: 3.996

3.  Effects of 1,4-butanediol administration on oxidative stress in rat brain: study of the neurotoxicity of gamma-hydroxybutyric acid in vivo.

Authors:  Angela M Sgaravatti; Alessandra S Magnusson; Amanda S Oliveira; Caroline P Mescka; Fernanda Zanin; Mirian B Sgarbi; Carolina D Pederzolli; Angela T S Wyse; Clóvis M D Wannmacher; Moacir Wajner; Carlos S Dutra-Filho
Journal:  Metab Brain Dis       Date:  2009-03-19       Impact factor: 3.584

4.  Profiling of oxidative stress in patients with inborn errors of metabolism.

Authors:  Peter J Mc Guire; Aditya Parikh; George A Diaz
Journal:  Mol Genet Metab       Date:  2009-06-14       Impact factor: 4.797

Review 5.  The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies.

Authors:  M Wajner; A Latini; A T S Wyse; C S Dutra-Filho
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

6.  A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency.

Authors:  John M Schreiber; Edythe Wiggs; Rose Cuento; Gina Norato; Irene H Dustin; Rachel Rolinski; Alison Austermuehle; Xiangping Zhou; Sara K Inati; K Michael Gibson; Phillip L Pearl; William H Theodore
Journal:  J Child Neurol       Date:  2021-05-20       Impact factor: 1.987

Review 7.  Succinic Semialdehyde Dehydrogenase Deficiency: An Update.

Authors:  Miroslava Didiášová; Antje Banning; Heiko Brennenstuhl; Sabine Jung-Klawitter; Claudio Cinquemani; Thomas Opladen; Ritva Tikkanen
Journal:  Cells       Date:  2020-02-19       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.